Skip to main content
PeerJ logoLink to PeerJ
. 2016 Feb 22;4:e1736. doi: 10.7717/peerj.1736

Cardiovascular manifestations of renovascular hypertension in diabetic mice

Sonu Kashyap 1, Sean Engel 1,2, Mazen Osman 1, Yousif Al-Saiegh 3, Asarn Wongjarupong 4, Joseph P Grande 1,5,
Editor: Julia Kzhyshkowska
PMCID: PMC4768709  PMID: 26925344

Abstract

Purpose. Type 2 diabetes is the leading cause of end stage renal disease in the United States. Atherosclerotic renal artery stenosis is commonly observed in diabetic patients and impacts the rate of renal and cardiovascular disease progression. We sought to test the hypothesis that renovascular hypertension, induced by unilateral renal artery stenosis, exacerbates cardiac remodeling in leptin-deficient (db/db) mice, which serves as a model of human type II diabetes.

Methods. We employed a murine model of renovascular hypertension through placement of a polytetrafluoroethylene cuff on the right renal artery in db/db mice. We studied 109 wild-type (non-diabetic, WT) and 95 db/db mice subjected to renal artery stenosis (RAS) or sham surgery studied at 1, 2, 4, and 6+ weeks following surgery. Cardiac remodeling was assessed by quantitative analysis of the percent of myocardial surface area occupied by interstitial fibrosis tissue, as delineated by trichrome stained slides. Aortic pathology was assessed by histologic sampling of grossly apparent structural abnormalities or by section of ascending aorta of vessels without apparent abnormalities.

Results. We noted an increased mortality in db/db mice subjected to RAS. The mortality rate of db/db RAS mice was about 23.5%, whereas the mortality rate of WT RAS mice was only 1.5%. Over 60% of mortality in the db/db mice occurred in the first two weeks following RAS surgery. Necropsy showed massive intrathoracic hemorrhage associated with aortic dissection, predominantly in the ascending aorta and proximal descending aorta. Aortas from db/db RAS mice showed more smooth muscle dropout, loss of alpha smooth muscle actin expression, medial disruption, and hemorrhage than aortas from WT mice with RAS. Cardiac tissue from db/db RAS mice had more fibrosis than did cardiac tissue from WT RAS mice.

Conclusions. db/db mice subjected to RAS are prone to develop fatal aortic dissection, which is not observed in WT mice with RAS. The db/db RAS model provides the basis for future studies directed towards defining basic mechanisms underlying the interaction of hypertension and diabetes on the development of aortic lesions.

Keywords: Renal artery stenosis, Cardiovascular disease, Diabetes, Hypertension

Introduction

Diabetes, hypertension, and hyperlipidemia are major risk factors for the development of cardiovascular disease, the leading cause of death in the United States (Lee et al., 2014). Diabetes is the most common cause of chronic renal disease, and is responsible for up to 50% of end stage renal disease cases in developed countries (Tuttle et al., 2014). In addition to increased risk for myocardial infarction and stroke, patients with diabetes are prone to develop a diabetic cardiomyopathy, characterized by extensive fibrotic changes and cardiomyocyte hypertrophy, leading to increased myocardial stiffness and diastolic dysfunction (Asbun & Villarreal, 2006; Rydén et al., 2013).

Hypertension is a major risk factor for both renal disease progression and cardiovascular morbidity and mortality in patients with type 2 diabetes (Ghaderian et al., 2015). Atherosclerotic renal artery stenosis is one of the most common causes of secondary hypertension (Safian & Textor, 2001). The prevalence of renal artery stenosis approaches 7% in individuals greater than 65 years of age and is up to 45% in patients with coronary artery or aortoiliac disease (Hansen et al., 2002; Weber-Mzell et al., 2002; Iglesias et al., 2000). The prevalence of renal artery stenosis varies from 17–44% in patients with hypertension and diabetes (Valabhji et al., 2000).

It is well recognized that renal artery stenosis promotes cardiac remodeling, characterized by replacement of myocardial tissue with extracellular matrix (Khan et al., 2014; Al-Suraih & Grande, 2014). However, mechanisms underlying the additive or synergistic effects of renovascular hypertension and cardiac remodeling have not been adequately addressed in previous studies. In order to address this issue, we have established a murine model of diabetic renovascular disease through placement of a cuff on the right renal artery of leptin deficient mice (db/db mice), which develop obesity and type 2 diabetes (Hartono et al., 2014).

Throughout the course of our studies, we found an increased incidence of sudden death in db/db mice subjected to renal artery stenosis (RAS), which was not observed in wild-type mice subjected to RAS. Necropsy of mice available for analysis revealed massive hemothorax and/or hemoperitoneum, which was associated with aortic dissection.

The objective of this study was to characterize the aortic and cardiac phenotype of db/db mice subjected to RAS. We found that cardiac tissue from db/db RAS mice had more fibrosis than did cardiac tissue from WT RAS mice studied at greater than 2 weeks following surgery. Aortas from db/db RAS mice had more smooth muscle dropout, medial disruption, and hemorrhage than did aortas from WT mice with RAS at both early (less than 2 weeks) and late time points (greater than 2 weeks). The db/db RAS model provides the basis for future studies directed towards defining basic mechanisms underlying the interaction of hypertension and diabetes on the development of aortic lesions.

Methods

Animal model

For survival analysis, a total of C57BLKS (WT) (N = 109) and C57BLKS/JLepr (db/db) (N = 95) male mice, (Jackson Laboratory, Bar Harbor, ME, USA) were studied. Both WT and db/db mice at 6–7 weeks age underwent RAS or sham surgery through placement of a polytetrafluoroethylene cuff (0.2 mm internal diameter) on the right renal artery, as previously described (N = 68 for WT and N = 64 db/db) (Warner et al., 2012; Wang et al., 2013). Sham surgery was performed through manipulation of the right renal artery without placement of the cuff (N = 41 for WT and N = 31 db/db). Mice were sacrificed at 1 week (N = 33 WT RAS, N = 22 WT sham, N = 18 db/db RAS, N = 5 db/db sham), 2 weeks (N = 8 WT RAS, N = 5 WT sham, N = 17 db/db RAS, N = 8 db/db sham), 4 weeks (N = 10 WT RAS, N = 5 WT sham, N = 8 db/db RAS, N = 5 db/db sham), 6 weeks (N = 10 WT RAS, N = 5 WT sham, N = 13 db/db RAS, N = 8 db/db sham), and 17 weeks (N = 7 WT RAS, N = 4 WT sham, N = 8 db/db RAS, N = 5 db/db sham).

For analysis of aortas and heart, a total of 38 WT RAS (N = 18 harvested at week 1, N = 3 week 4, N = 10 week 6, and N = 7 week 17), 19 WT sham (N = 5 week 1, N = 5 week 2, N = 5 week 6, and N = 4 week 17), 48 db/db RAS (N = 11 week 1, N = 10 week 2, N = 7 week 4, N = 12 week 6, N = 8 week 17), and 22 db/db sham (N = 5 week 1, N = 3 week 2, N = 9 week 6, and N = 5 week 17) were studied. The animals studied were divided into early time point (pre 2 weeks following surgery) and late time point (post 2 weeks following surgery) groups.

All animal protocols were approved by the Mayo Clinic Institutional Animal Care and Use Committee for appropriate experiments (IACUC Protocol Number A62613).

Histological and Immunohistochemical analysis

Aortas were carefully examined for grossly apparent abnormalities, including dilation, medial disruption, or hemorrhage. Five aortas, obtained from db/db RAS mice that died suddenly, showed evidence of aortic dissections involving the ascending or proximal descending aorta. If there were no grossly apparent abnormalities, a section of ascending aorta, taken from the same site among samples, was submitted for histologic processing. Aorta and heart tissues were fixed with 10% neutral buffered formalin and then processed for histology or immunohistochemistry using standard techniques. Histological sections of heart and aorta (5 µm thick) were stained with hematoxylin-eosin (H & E). H & E was used for scoring the aorta pathology and aortic diameter. The aortic score numbers were represented as, 0 = normal aorta; 1 = isolated smooth muscle dropout; 2 = multifocal smooth muscle dropout; 3 = hemorrhage, necrosis, dissection, or mural thrombosis. Slides were read in a blinded fashion. Heart sections were also stained with Masson’s trichrome stain and used for the quantification of fibrosis. Width of aorta and percentage of fibrosis in heart trichrome sections were quantified at 200× magnification using an Olympus BX50 microscope (Olympus America, Melville, NY, USA), a Micropublisher 3.3 RTV camera (Q-Imaging, Surrey, BC, CAN), and the NIS Elements Imaging Software (Nikon Instruments, Inc., Melville, NY, USA).

Sections of aortas were stained for alpha smooth muscle actin (1:500, Abcam Inc., Cambridge, MA, USA). Loss of alpha smooth muscle actin in the media of aortas was semiquantitatively assessed as 0 = none, 1 = isolated, 2 = multifocal, and 3 = generalized. Assessment was conducted in a blinded fashion.

Statistical analysis

Data are presented as mean ± SEM. Comparisons between two groups were done using student t-test for parametric data and Mann–Whitney test for nonparametric data. For comparison across multiple groups, one-way ANOVA followed by a Turkey adjustment was used for post-hoc comparison of the measurements. P values <0.05 were considered significant. Correlation analysis and all statistical comparisons were performed using Graphpad Prism 6 (GraphPad Software, La Jolla, CA, USA).

Results

A summary of heart weight, body weight and heart-to-body weight ratio at time of analysis is provided in Table 1. In accordance with our previous studies, both db/db RAS and WT RAS mice became hypertensive within 1 week and remained hypertensive thereafter, with no significant differences between db/db RAS and WT RAS at any time point (Hartono et al., 2014). As expected, the weight of both db/db sham and db/db RAS mice was significantly greater than that of WT sham and WT RAS mice. Although the heart weight of db/db RAS mice was significantly higher than that of db/db sham mice at late time point, this difference was not significant after correction for body weight (Table 1). However, the heart weight of WT RAS mice corrected for body weight was significantly greater than that of WT sham mice corrected for body weight at early time point (Table 1). At both time points, the heart weight to body weight ratio in WT sham mice was significantly greater than that of db/db sham mice (Table 1).

Table 1. Mean ± SEM body weight, heart weight and the heart-to-body weight ratio of WT and db/db mice groups.

Mice group Early time point Late time point
Body weight (g) Heart weight (mg) Heart/body weight ratio Body weight (g) Heart weight (mg) Heart/body weight ratio
WT RAS 18.9 ± 0.5a 134.4 ± 4.5 7.1 ± 0.2d,e 23.7 ± 0.5a 146.8 ± 3.5c 6.2 ± 0.2d
db/db RAS 32.5 ± 0.8a 140.0 ± 3.1 4.4 ± 0.1d 38.6 ± 1.4a,b 183.1 ± 9.1c 4.9 ± 0.3d
WT Sham 21.1 ± 0.2a 125.0 ± 3.7 5.9 ± 0.2e,d 25.8 ± 0.4b 143.3 ± 5.0 5.6 ± 0.1e
db/db Sham 33.3 ± 1.2a 131.4 ± 6.3 4.0 ± 0.1e 32.7 ± 1.6b 131.4 ± 5.8c 4.2 ± 0.3e

Notes.

a

p < 0.001 = Body weight comparison between db/db RAS vs WT RAS at both early and late time points, WT sham vs db/db sham early time point.

b

p < 0.05 = Body weight comparison between WT sham vs db/db sham late time point, db/db RAS vs db/db sham at late time point.

c

p < 0.001 = Heart weight comparison between db/db RAS vs WT RAS at late time point, db/db RAS vs db/db sham at late time point.

d

p < 0.001 = Heart-to-body weight ratio comparison between db/db RAS vs WT RAS at both early and late time points, WT sham vs db/db sham early time point.

e

p < 0.05 = Heart-to-body weight ratio comparison between WT sham vs db/db sham late time point, WT RAS vs WT sham early time point.

db/db mice with RAS had a higher mortality rate than WT mice with RAS

Fifteen of 64 (23.4%) db/db mice subjected to RAS died suddenly, whereas only 1 death was observed in 64 WT mice with RAS (1.5%, p < 0.001). Mortality of db/db mice as a function of time following RAS surgery is summarized in Table 2. Necropsy, performed on 7 of the db/db mice that died suddenly, showed massive intrathoracic hemorrhage with evidence of aortic dissection. The dissections appeared to occur in the ascending aorta (Fig. 1) or the proximal descending thoracic aorta. The aorta of the WT mouse that died suddenly was without grossly apparent or histopathologic abnormality. Approximately 60% of deaths in the db/db mice occurred in the two weeks following RAS surgery (Table 2).

Table 2. Number of mortality observed in WT and db/db mice as function of time.

db/db RAS mice showed the highest mortality.

Days following surgery
Mice group 1 3 4 5 7 9 14 28 40 61 90 104 117
db/db/ RAS 1 2 1 2 2 0 1 1 1 1 1 1 1
db/db/ Sham 0 0 0 0 0 0 0 0 0 0 0 0 0
WT/RAS 0 0 0 0 0 1 0 0 0 0 0 0 0
WT/Sham 0 0 0 0 0 0 0 0 0 0 0 0 0

Figure 1. Photograph of aorta dissection showing the severe rupture just distal to aortic root.

Figure 1

Representative photograph of aortic rupture. In the study, most aortic ruptures were found in the ascending aorta.

Severity of aortic histopathologic lesions was greater in db/db RAS mice than WT RAS mice

Aortas were obtained for histopathologic analysis on 38 WT RAS mice (18 at week 1, 3 at week 4, 10 at week 6, and 7 at week 17), 19 WT sham mice (5 at week 1, 5 at week 2, 5 at week 6, and 4 at week 17), 48 db/db RAS mice (11 at week 1, 10 at week 2, 7 at week 4, 12 at week 6, and 8 at week 17), and 22 db/db sham mice (5 at week 1, 3 at week 2, 9 at week 6, and 5 at week 17. Histologic sections were obtained from the ascending aorta and proximal descending thoracic aorta, sites where grossly apparent aortic dissections were observed. If no aortic abnormalities were grossly apparent, a standard section of ascending aorta was obtained. A semiquantitative scoring system was employed to assess severity of aortic pathology, including medial smooth muscle dropout, medial disruption, hemorrhage, or necrosis; slides were read in a blinded fashion. Given that a majority of the sudden deaths in db/db mice with RAS occurred within the first 2 weeks following surgery, we compared histopathologic alterations in the aorta of mice studied at 2 weeks or less following surgery with those in the aorta of animals studied at greater than 2 weeks following surgery. No damage was found in the aortas of any db/db or WT sham mice. Aortic damage was observed in both db/db and WT RAS mice. Typical histopathologic alterations included medial smooth muscle dropout and medial disruption with hemorrhage (Figs. 2A2D). At both early and late time points, db/db RAS mice showed a significantly increased aortic pathology score compared to WT RAS mice (Fig. 2E). Loss of aortic medial smooth muscle cells was associated with local or generalized reduction in medial alpha-smooth muscle actin expression (Fig. 3). Loss of alpha smooth muscle actin expression was significantly correlated with aortic pathology score in db/db mice subjected to RAS and studied at early time points (r2 = 0.62, p ≤ 0.0001). Alpha smooth muscle actin scores did not significantly correlate with aortic pathology scores in db/db RAS mice studied at late time points or in WT RAS mice studied at early or late time points.

Figure 2. db/db mice showed higher mean pathology score at both early and late time points.

Figure 2

Representative images of aorta illustrating semiquantitative histologic assessment scores. (A) Shows normal aorta (score of 0). (B) Focal myocyte dropout (Score of 1). (C) Multifocal myocyte dropout (Score of 2). (D) Medial disruption and hemorrhage (Score of 3). Mean pathology score of db/db and WT early and late time points animals subjected to RAS surgery. p = 0.007, ∗∗p = 0.0034 in comparison to WT group.

Figure 3. db/db mice showed more α smooth muscle actin loss in aorta at both early and late time points compared to WT.

Figure 3

Representative images of aorta illustrating semiquantitative assessment of α smooth muscle actin (α SMA) loss at 400× using α SMA staining. (A) shows no loss of α SMA stain (score of 0). (B) Focal loss of α SMA stain (Score of 1). (C) Multifocal loss of α SMA stain (Score of 2). D. extensive loss of α SMA stain (Score of 3). (E) Mean α SMA stain loss score of db/db and WT early and late time points animals. p = 0.0152, ∗∗p = 0.002, #p = 0.0001 in comparison to respective sham groups. $p = 0.0001.

Increase in Aortic wall width observed in damaged aortae in both WT and db/db RAS mice

To determine whether aortic histopathologic alterations were associated with increased medial thickness, the aortic width was examined at 200×magnification, from the internal elastic lamina to the adventitia in WT and db/db RAS mice. Aortas demonstrating normal histopathology (score = 0) were compared with those showing isolated smooth muscle dropout (score = 1), multifocal smooth muscle dropout (score = 2) or evidence of medial disruption, hemorrhage, or necrosis (score = 3). The wall thickness of aortas showing minor to severe histopathologic abnormalities was significantly greater than that of aortas showing normal histopathology, in both db/db and WT RAS mice (p = 0.002 for db/db and p = 0.000 for WT) (Fig. 4).

Figure 4. Abnormal aorta showed increased overall wall thickness.

Figure 4

Mean aortic medial thickness was greater in aortas with histopathological scores of 1, 2, or 3 versus a score of 0 in both WT and db/db mice (p = 0.002, ∗∗p = 0.0001).

db/db RAS mice showed more cardiac fibrosis

Myocardial remodeling was determined as the percentage of surface area staining blue with trichrome stain, as assessed by computer-assisted quantitative morphometric analysis. Representative photomicrographs are shown in Figs. 5A5D. Cardiac fibrosis was increased in both db/db and WT RAS mice compared to their sham at both early and late time points (Fig. 5E). There was a significantly higher degree of fibrosis in db/db RAS mice compared to WT RAS mice at time points greater than 2 weeks (Figs. 5E). The extent of cardiac fibrosis did not correlate with aortic pathology.

Figure 5. Increased cardiac fibrosis in db/db RAS mice compared to WT at later time points.

Figure 5

Myocardial fibrosis was assessed by quantitative image analysis of trichrome stained sections at 200× magnification obtained from (A) WT sham, (B) db/db sham, (C) WT RAS and (D) db/db RAS mice (E). The mean percentage of fibrosis in db/db and WT mice at early and late time points. Both WT and db/db showed increase % fibrosis following RAS compared to their respective sham at both early and late time points. db/db RAS mice had significantly more fibrosis compared to WT RAS at late time points. p = 0.02, ∗∗p = 0.009, #p = 0.001, $p = 0.0001 compared to their respective shams and &p = 0.03.

Discussion

We unexpectedly found an increased prevalence of aortic dissection leading to sudden death in db/db but not WT mice subjected to RAS. Aortas showed more medial smooth muscle dropout, medial disruption and hemorrhage in db/db mice than WT mice with RAS. Aortic lesions were observed in the ascending and proximal descending aorta, which are common sites for human aortic dissection.

Although a well-established risk factor for atherosclerosis, diabetes is associated with a reduced prevalence of atherosclerotic aortic aneurysms (Takagi & Umemoto, 2015; Golledge, Cooper & Chai, 2015; Pafili et al., 2015; Pafili, Gouni-Berthold & Papanas, 2015). It is thought that production of advanced glycation end products and extracellular matrix deposition may lead to reduced macrophage infiltration, matrix metalloproteinase activity, and plasmin activation (Pafili et al., 2015). In the current study, we did not find any significant difference in aortic medial thickness between db/db and WT mice subjected to RAS. Furthermore, we did not find any evidence of atherosclerosis in the db/db mice. In order to reduce potential complications associated with delayed wound healing in older db/db mice, we performed RAS surgery on young (6–7 weeks old) mice, prior to the development of end organ manifestations of diabetes.

Aortic aneurysms and dissection result from either genetic or acquired defects in the aortic wall. Since aortic aneurysms are typically asymptomatic until they rupture, it is important to better characterize the pathophysiology of aortic aneurysms and to identify patients who are at increased risk of developing these catastrophic lesions. Several animal models of aortic aneurysms have been developed to elucidate basic mechanisms underlying the development of these lesions (Baker et al., 1984).

Ang II infusion in atherosclerotic Apolipoprotein E (Apo-E) deficient mice has been employed as a model of aortic aneurysms (Baker et al., 1984; Van Kats et al., 1998; Daugherty et al., 2010). In addition to increasing blood pressure, Ang II promotes influx of T cells and macrophages into the aorta and other vessels (Lindpaintner & Ganten, 1991). Ang II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice (Qian & Montgomery, 2012). These studies suggest that the pro-inflammatory effect of Ang II is more important than its hypertensive effect in the development of aortic aneurysms (Qian & Montgomery, 2012). Along these lines, the incidence of both atherosclerosis and of aortic aneurysms is significantly reduced in Apo-E deficient mice lacking CCR2, a critical receptor that directs influx of macrophages and T cells to sites of tissue injury (Daugherty et al., 2010). Although endogenous angiotensin II production is likely responsible for the development of aortic lesions in mice with RAS, the dissections observed in the current study were observed primarily in the ascending and proximal descending aorta, whereas angiotensin II infused mice tend to develop abdominal aortic aneurysms (Baker et al., 1984; Qian & Montgomery, 2012; Clauser, 1998). Mononuclear cell infiltrates were observed in both WT and db/db RAS mice, in accordance with studies indicating that angiotensin II promotes vascular inflammation (Klingbeil et al., 2003; Harrison et al., 2010). However, we did not observe any significant differences in the severity of mononuclear cell infiltrates between WT and db/db RAS mice in this study.

Recent studies have defined a critical role for TGF-β signaling in the pathogenesis of aortic aneurysms and dissection. TGF-β signaling is initiated through binding of TGF-β to the type 2 receptor (TBR2), recruitment of the type 1 receptor (TBR1), followed by phosphorylation of SMAD3, recruitment of SMAD4, nuclear translocation and activation of target genes (Cheng & Grande, 2002; Cheng & Grande, 2009). Mutations in SMAD3, have been identified in up to 2% of patients with familial thoracic aneurysms leading to acute aortic dissection (Regalado et al., 2011) Patients with the Loeys-Dietz syndrome have mutations in receptors for TGF-β (TGFBR1 and TGFBR2) (Loeys et al., 2006).

In mice with homozygous deletion of the Smad3 gene, angiotensin II (Ang II) infusion promotes the development of aortic aneurysms and aortic dissection. Development of aneurysms is due to Ang II mediated macrophage infiltration and upregulation of NOS2 (inducible nitric oxide synthase), matrix metalloproteinases (MMP) 2 and 9 rather than hypertension alone (Tan et al., 2013). Of note, we did not observe any aortic dissections in our previous study employing RAS in mice bearing homozygous deletion of the Smad3 gene (Warner et al., 2012).

In addition to the increased risk of developing ischemic heart disease, patients with diabetes are prone to develop diabetic cardiomyopathy, characterized by cardiac hypertrophy, myocardial fibrosis, and diastolic dysfunction (Asbun & Villarreal, 2006) Although leptin-deficient db/db mice do not develop myocardial remodeling or cardiac dysfunction, they are more susceptible to Ang II mediated hypertrophy and dysfunction (Harrap et al., 1996). Along these lines, we observed more severe cardiac remodeling in db/db RAS mice than WT RAS mice. Smad3 null mice crossed with leptin deficient db/db diabetic mice were protected from the development of diabetic cardiomyopathy (Biernacka et al., 2015). However, db/db SMAD3 null mice showed increased mortality due to spontaneous rupture of the ascending aorta (Biernacka et al., 2015). SMAD3 deficiency was associated with increased MMP-2 and MMP-9 activity, with no change in tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) activity.

In mice fed a high fat diet or obese ob/ob mice, Ang II infusion promotes macrophage influx into the aorta and fosters the development of aortic aneurysms (Clauser, 1998). In our model, which employs endogenous activation of the renin-angiotensin system due to renal artery stenosis (Warner et al., 2012; Wang et al., 2013; Cheng et al., 2009) we find that db/db mice are more susceptible to both renal and cardiovascular disease than WT mice, despite similar elevation in systolic blood pressure (Hartono et al., 2014). In our previous study of db/db mice subjected to RAS, we found that angiotensin I production is elevated in both db/db and WT mice, but returns to baseline levels by 6 weeks following surgery (Hartono et al., 2014), making it unlikely that differences in blood pressure or angiotensin II production are responsible for the development of aortic dissection in db/db mice.

Although we believe that this is the first study to document aortic lesions in db/db mice subjected to renovascular hypertension, there are several limitations. First, this was a retrospective study which was not designed to identify aortic lesions. It was not possible to perform histopathologic analysis on many of the mice that died suddenly. Nevertheless, we were able to identify more aortic lesions in db/db mice, even in vessels with no grossly apparent pathology. Finally, we have not established a potential mechanism through which hyperglycemia/diabetes interacts with renovascular hypertension to produce the aortic lesions. This may be at least in part due to the fact that many, if not most, of the aortas obtained from both db/db or WT mice had minor histopathologic abnormalities. Although an effort was made to sample grossly abnormal regions of the aorta, the focal nature of the lesions may lead to an underestimation of the degree of histologic abnormalities, including macrophage infiltration.

Placement of a cuff on the right renal artery produces kidney lesions that recapitulate many of the histopathologic features of human renal artery stenosis (Keddis et al., 2010). The stenotic kidney of mice with RAS develops progressive tubular atrophy, interstitial inflammation, and interstitial fibrosis (Wang et al., 2013; Cheng et al., 2009), whereas the contralateral kidney undergoes compensatory enlargement with minimal histopathologic abnormalities. Unlike WT mice, db/db mice subjected to RAS develop bilateral, progressive renal disease, with severe atrophy of the stenotic kidney and diffuse mesangial sclerosis, with segmental and global glomerulosclerosis, interstitial fibrosis, and tubular atrophy—features reminiscent of diabetic nephropathy. Of note, the severity of renal or cardiac lesions did not correlate with aortic pathology. Future studies will determine whether the diabetic phenotype interacts with the pro-inflammatory state driven by elevated Ang II levels and will define maladaptive signaling pathways triggered through which hyperglycemia/diabetes intersect with renovascular hypertension to produce aortic dissection.

Supplemental Information

Figure S1. Data used for the Figs. 2, 3 and 4E.
DOI: 10.7717/peerj.1736/supp-1
Data S1. Raw dataset used for the paper.
DOI: 10.7717/peerj.1736/supp-2

Acknowledgments

We thank Karen Lien for assistance with histology.

Funding Statement

This study was supported by NIH/NIAID R01 AI100911-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Additional Information and Declarations

Competing Interests

The authors declare there are no competing interests.

Author Contributions

Sonu Kashyap conceived and designed the experiments, performed the experiments, analyzed the data, wrote the paper, prepared figures and/or tables, reviewed drafts of the paper.

Sean Engel performed the experiments, analyzed the data, wrote the paper, prepared figures and/or tables.

Mazen Osman, Yousif Al-Saiegh and Asarn Wongjarupong performed the experiments, analyzed the data.

Joseph P. Grande conceived and designed the experiments, contributed reagents/materials/analysis tools, wrote the paper, reviewed drafts of the paper.

Animal Ethics

The following information was supplied relating to ethical approvals (i.e., approving body and any reference numbers):

Mayo Clinic IACUC protocol number A62613.

Data Availability

The following information was supplied regarding data availability:

Data can be found in the Supplemental Information.

References

  • Al-Suraih & Grande (2014).Al-Suraih M, Grande JP. Management of renal artery stenosis: what does the experimental evidence tell us? World Journal of Cardiology. 2014;6(8):855–860. doi: 10.4330/wjc.v6.i8.855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Asbun & Villarreal (2006).Asbun J, Villarreal FJ. The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. Journal of the American College of Cardiology. 2006;47(4):693–700. doi: 10.1016/j.jacc.2005.09.050. [DOI] [PubMed] [Google Scholar]
  • Baker et al. (1984).Baker KM, Campanile CP, Trachte GJ, Peach MJ. Identification and characterization of the rabbit angiotensin II myocardial receptor. Circulation Research. 1984;54(3):286–293. doi: 10.1161/01.RES.54.3.286. [DOI] [PubMed] [Google Scholar]
  • Biernacka et al. (2015).Biernacka A, Cavalera M, Wang J, Russo I, Shinde A, Kong P, Gonzalez-Quesada C, Rai V, Dobaczewski M, Lee D-WW, Wang X-F, Frangogiannis NG. Smad3 signaling promotes fibrosis while preserving cardiac and aortic geometry in obese diabetic mice. Circulation Heart failure. 2015;8(4):788–798. doi: 10.1161/CIRCHEARTFAILURE.114.001963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Cheng & Grande (2002).Cheng JF, Grande JP. Transforming growth factor-beta signal transduction and progressive renal disease. Experimental Biology & Medicine. 2002;227(11):943–956. doi: 10.1177/153537020222701102. [DOI] [PubMed] [Google Scholar]
  • Cheng & Grande (2009).Cheng J, Grande JP. Transforming growth factor-B and kidney dysfunction. Journal of Organ Dysfunction. 2009;5(3):182–192. doi: 10.1080/17471060701649962. [DOI] [Google Scholar]
  • Cheng et al. (2009).Cheng J, Zhou W, Warner GM, Knudsen BE, Garovic VD, Gray CE, Lerman LO, Platt JL, Romero JC, Textor SC, Nath KA, Grande JP. Temporal analysis of signaling pathways activated in a murine model of 2-kidney, 1-clip hypertension. American Journal of Physiology. Renal Physiology. 2009;297(4):F1055–F1068. doi: 10.1152/ajprenal.90439.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Clauser (1998).Clauser E. [Molecular structure and function of angiotensin ii receptors] Nephrologie. 1998;19(7):403–410. [PubMed] [Google Scholar]
  • Daugherty et al. (2010).Daugherty A, Rateri DL, Charo IF, Owens AP, Howatt DA, Cassis LA. Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE-/- mice. Clinical Science. 2010;118(11):681–689. doi: 10.1042/CS20090372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Ghaderian et al. (2015).Ghaderian SB, Hayati F, Shayanpour S, Beladi Mousavi SS. Diabetes and end-stage renal disease; a review article on new concepts. Journal of renal injury prevention. 2015;4(2):28–33. doi: 10.12861/jrip.2015.07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Golledge, Cooper & Chai (2015).Golledge J, Cooper ME, Chai Z. Diabetes and aortic aneurysm. Angiology. 2015:1–3. doi: 10.1177/0003319715606255. Epub ahead of print Sep 28 2015. [DOI] [PubMed] [Google Scholar]
  • Hansen et al. (2002).Hansen KJ, Edwards MS, Craven TE, Cherr GS, Jackson SA, Appel RG, Burke GL, Dean RH. Prevalence of renovascular disease in the elderly: a population-based study. Journal of Vascular Surgery. 2002;36(3):443–451. doi: 10.1067/mva.2002.127351. [DOI] [PubMed] [Google Scholar]
  • Harrap et al. (1996).Harrap SB, Dominiczak AF, Fraser R, Lever AF, Morton JJ, Foy CJ, Watt GC. Plasma angiotensin II, predisposition to hypertension, and left ventricular size in healthy young adults. Circulation. 1996;93(6):1148–1154. doi: 10.1161/01.CIR.93.6.1148. [DOI] [PubMed] [Google Scholar]
  • Harrison et al. (2010).Harrison DG, Vinh A, Lob H, Madhur MS. Role of the adaptive immune system in hypertension. Current Opinion in Pharmacology. 2010;10(2):203–207. doi: 10.1016/j.coph.2010.01.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Hartono et al. (2014).Hartono SP, Knudsen BE, Lerman LO, Textor SC, Grande JP. Combined effect of hyperfiltration and renin angiotensin system activation on development of chronic kidney disease in diabetic db/db mice. BMC Nephrology. 2014;15(1):58. doi: 10.1186/1471-2369-15-58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Iglesias et al. (2000).Iglesias JI, Hamburger RJ, Feldman L, Kaufman JS. The natural history of incidental renal artery stenosis in patients with aortoiliac vascular disease. American Journal of Medicine. 2000;109(8):642–647. doi: 10.1016/S0002-9343(00)00605-7. [DOI] [PubMed] [Google Scholar]
  • Keddis et al. (2010).Keddis MT, Garovic VD, Bailey KR, Wood CM, Raissian Y, Grande JP. Ischaemic nephropathy secondary to atherosclerotic renal artery stenosis: clinical and histopathological correlates. Nephrology, Dialysis, Transplantation. 2010;25(11):3615–3622. doi: 10.1093/ndt/gfq269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Khan et al. (2014).Khan AR, Sheikh M, Kaw D, Cooper CJ, Khouri SJ. Prevalence and factors associated with left ventricular remodeling in renal artery stenosis. Journal of the American Society of Hypertension. 2014;8(4):254–261. doi: 10.1016/j.jash.2014.01.008. [DOI] [PubMed] [Google Scholar]
  • Klingbeil et al. (2003).Klingbeil AU, Schneider M, Martus P, Messerli FH, Schmieder RE. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. American Journal of Medicine. 2003;115(1):41–46. doi: 10.1016/S0002-9343(03)00158-X. [DOI] [PubMed] [Google Scholar]
  • Lee et al. (2014).Lee MS, Flammer AJ, Kim HS, Hong JY, Li J, Lennon RJ, Lerman A. The prevalence of cardiovascular disease risk factors and the Framingham Risk Score in patients undergoing percutaneous intervention over the last 17 years by gender: time-trend analysis from the Mayo Clinic PCI Registry. Journal of Preventive Medicine and Public Health. 2014;47(4):216–229. doi: 10.3961/jpmph.2014.47.4.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Lindpaintner & Ganten (1991).Lindpaintner K, Ganten D. The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence. Circulation Research. 1991;68(4):905–921. doi: 10.1161/01.RES.68.4.905. [DOI] [PubMed] [Google Scholar]
  • Loeys et al. (2006).Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, De Backer JF, Oswald GL, Symoens S, Manouvrier S, Roberts AE, Faravelli F, Greco MA, Pyeritz RE, Milewicz DM, Coucke PJ, Cameron DE, Braverman AC, Byers PH, De Paepe AM, Dietz HC. Aneurysm syndromes caused by mutations in the TGF-beta receptor. New England Journal of Medicine. 2006;355(8):788–798. doi: 10.1056/NEJMoa055695. [DOI] [PubMed] [Google Scholar]
  • Pafili, Gouni-Berthold & Papanas (2015).Pafili K, Gouni-Berthold I, Papanas N. Abdominal aortic aneurysms: do not underestimate the role of diabetes. Expert Review of Cardiovascular Therapy. 2015;13(12):1289–1290. doi: 10.1586/14779072.2015.1100537. [DOI] [PubMed] [Google Scholar]
  • Pafili et al. (2015).Pafili K, Gouni-Berthold I, Papanas N, Mikhailidis DP. Abdominal aortic aneurysms and diabetes mellitus. Journal of Diabetes and its Complications. 2015;29(8):1330–1336. doi: 10.1016/j.jdiacomp.2015.08.011. [DOI] [PubMed] [Google Scholar]
  • Qian & Montgomery (2012).Qian F, Montgomery RR. Quantitative imaging of lineage-specific toll-like receptor-mediated signaling in monocytes and dendritic cells from Small Samples of Human Blood. Journal of Visualized Experiments. 2012;62:e1736. doi: 10.3791/3741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Regalado et al. (2011).Regalado ES, Guo DC, Villamizar C, Avidan N, Gilchrist D, McGillivray B, Clarke L, Bernier F, Santos-Cortez RL, Leal SM, Bertoli-Avella AM, Shendure J, Rieder MJ, Nickerson DA, Milewicz DM. Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms. Circulation Research. 2011;109(6):680–686. doi: 10.1161/CIRCRESAHA.111.248161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Rydén et al. (2013).Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes HP, Huikuri H, Marre M, Marx N, Mellbin L, Ostergren J, Patrono C, Seferovic P, Uva MS, Taskinen MR, Tendera M, Tuomilehto J, Valensi P, Zamorano JL, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, De Backer G, Sirnes PA, Ezquerra EA, Avogaro A, Badimon L, Baranova E, Baumgartner H, Betteridge J, Ceriello A, Fagard R, Funck-Brentano C, Gulba DC, Hasdai D, Hoes AW, Kjekshus JK, Knuuti J, Kolh P, Lev E, Mueller C, Neyses L, Nilsson PM, Perk J, Ponikowski P, Reiner Z, Sattar N, Schächinger V, Scheen A, Schirmer H, Strömberg A, Sudzhaeva S, Tamargo JL, Viigimaa M, Vlachopoulos C, Xuereb RG. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD) European Heart Journal. 2013;34(39):3035–3087. doi: 10.1093/eurheartj/eht108. [DOI] [PubMed] [Google Scholar]
  • Safian & Textor (2001).Safian RD, Textor SC. Renal-artery stenosis. New England Journal of Medicine. 2001;344(6):431–442. doi: 10.1056/NEJM200102083440607. [DOI] [PubMed] [Google Scholar]
  • Takagi & Umemoto (2015).Takagi H, Umemoto T, of Group A Diabetes and abdominal aortic aneurysm growth. Angiology. 2015:1–13. doi: 10.1177/0003319715602414. Epub ahead of print Aug 25 2015. [DOI] [PubMed] [Google Scholar]
  • Tan et al. (2013).Tan CK, Tan EH, Luo B, Huang CL, Loo JS, Choong C, Tan NS. SMAD3 deficiency promotes inflammatory aortic aneurysms in angiotensin II-infused mice via activation of iNOS. Journal of the American Heart Association. 2013;2(3):e1736. doi: 10.1161/JAHA.113.000269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Tuttle et al. (2014).Tuttle KR, Bakris GL, Bilous RW, Chiang JL, De Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME. Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care. 2014;37(10):2864–2883. doi: 10.2337/dc14-1296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Valabhji et al. (2000).Valabhji J, Robinson S, Poulter C, Robinson AC, Kong C, Henzen C, Gedroyc WM, Feher MD, Elkeles RS. Prevalence of renal artery stenosis in subjects with type 2 diabetes and coexistent hypertension. Diabetes Care. 2000;23(4):539–543. doi: 10.2337/diacare.23.4.539. [DOI] [PubMed] [Google Scholar]
  • Van Kats et al. (1998).Van Kats JP, Danser AH, Van Meegen JR, Sassen LM, Verdouw PD, Schalekamp MA. Angiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions. Circulation. 1998;98(1):73–81. doi: 10.1161/01.CIR.98.1.73. [DOI] [PubMed] [Google Scholar]
  • Wang et al. (2013).Wang D, Warner GM, Yin P, Knudsen BE, Cheng J, Butters KA, Lien KR, Gray CE, Garovic VD, Lerman LO, Textor SC, Nath KA, Simari RD, Grande JP. Inhibition of p38 MAPK attenuates renal atrophy and fibrosis in a murine renal artery stenosis model. American Journal of Physiology. Renal Physiology. 2013;304(7):F938–F947. doi: 10.1152/ajprenal.00706.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Warner et al. (2012).Warner GM, Cheng J, Knudsen BE, Gray CE, Deibel A, Juskewitch JE, Lerman LO, Textor SC, Nath KA, Grande JP. Genetic deficiency of Smad3 protects the kidneys from atrophy and interstitial fibrosis in 2K1C hypertension. American Journal of Physiology. Renal Physiology. 2012;302(11):F1455–F1464. doi: 10.1152/ajprenal.00645.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Weber-Mzell et al. (2002).Weber-Mzell D, Kotanko P, Schumacher M, Klein W, Skrabal F. Coronary anatomy predicts presence or absence of renal artery stenosis. A prospective study in patients undergoing cardiac catheterization for suspected coronary artery disease. European Heart Journal. 2002;23(21):1684–1691. doi: 10.1053/euhj.2002.3314. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Figure S1. Data used for the Figs. 2, 3 and 4E.
DOI: 10.7717/peerj.1736/supp-1
Data S1. Raw dataset used for the paper.
DOI: 10.7717/peerj.1736/supp-2

Data Availability Statement

The following information was supplied regarding data availability:

Data can be found in the Supplemental Information.


Articles from PeerJ are provided here courtesy of PeerJ, Inc

RESOURCES